drugset / Trial / NCT03658850
Safety and Efficacy of Hydrochlorothiazide in the Treatment of Hypernatremia in Critically Ill Patients
RandomizedParallel-groupTriple-blindTreatment
Summary
HYDRA is a randomized clinical trial designed to evaluate safety and efficiency of hydrochlorothiazide in critical patients with hypernatremia
Timeline
- Start
- 2018-10-01
- Primary completion
- 2019-12-10
- Completion
- 2020-03-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hydrochlorothiazide | Unknown | 50 mg | Other |
Indications
No indication recorded.